Recent Company News

• 04:49 PM ET Mar 20, 2026
  

  Bristol Myers Squibb announces that Opdivo (nivolumab) has received approval for two new classical Hodgkin Lymphoma (cHL) indications in the U.S. and the European Union (EU) ($57.48, 0.00)

• 02:00 PM ET Mar 09, 2026
  

  StreetAccount Summary - Private Company Weekly Recap - Week of 2-Mar

• 08:55 AM ET Mar 03, 2026
  

  Sinopia Biosciences (private) announces drug discovery collaboration with Ono Pharmaceutical for rare metabolic disorders (¥2488.0000, 0)

• 08:02 PM ET Mar 02, 2026
  

  Ono Pharmaceutical to expand drug discovery collaboration agreement with Congruence Therapeutic (¥2502.5000, -41)

• 10:08 PM ET Mar 01, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:15 AM ET Feb 27, 2026
  

  Ono Pharmaceutical to terminate co-promotion activities in Japan for Forxiga, transfer distribution and sales to AstraZeneca (¥2674.5000, 0)

• 11:27 PM ET Feb 26, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (151 total)

• 09:43 PM ET Feb 26, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (133 total)

• 11:23 PM ET Feb 24, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (240 total)

• 10:37 PM ET Feb 24, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (329 total)